The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Live-"APASL 2024 Kyoto-The Center of Hepatology"

Mar

27

Mar

28

Mar

29

Mar

30

Mar

31

Room 01
Room 02
Room 03
Room 04
Room 05
Room 06
Room 07
Room 08
Room 09
Room 10
Room 11
Room 12
Room 13
Room 14
Room 15
Room 16
New Hall

Room 01

09:00-10:30

APASL Targets for This Century

10:50-11:20

Opening Ceremony

11:20-11:45

Opening Lecture

11:45-12:10

Presidential Lecture

12:30-13:30

LS1 Gilead

13:40-15:10

Awarding Ceremony APASL Award Session

15:30-17:00

Global Steatosis Liver Disease Symposium APASL/AASLD/EASL/ALEH

17:10-18:10

State-of-the Art Lecture
Room 02

08:00-08:45

Hepatitis B - Clinical 1

08:45-09:30

Hepatitis B - Clinical 2

09:30-10:15

Hepatitis B - Clinical 3

12:30-13:30

LS2 AbbVie

13:40-15:10

HBV 1 Challenges for Elimination of CCC HBV DNA

15:30-17:00

Gilead

17:10-18:10

State of the Art Lecture
Room 03

08:00-08:45

Hepatitis B - Clinical 4

08:45-09:30

Hepatitis B - Clinical 5

09:30-10:15

Hepatitis B - Clinical 6

12:30-13:30

LS3 Taisho Pharmaceutical

13:40-15:10

HBV 2 Novel Detection Methods for HBV Markers

15:30-17:00

HBV 3 Functional Cure of CHB in Real World
Room 04

08:00-08:45

Hepatitis B - Clinical 7

08:45-09:30

Hepatitis B - Clinical 8

09:30-10:15

Hepatitis B - Clinical 9

12:30-13:30

LS4 Abbott

13:40-15:10

MAFLD 1 Asian MAFLD: Clinical Features

15:30-17:00

Novo Nordisk
Room 05

08:00-08:45

Hepatitis B - Clinical 10

08:45-09:30

Hepatitis B - Clinical 11

09:30-10:06

Hepatitis B - Clinical 12

12:30-13:30

LS5 Canon Medical

13:40-14:25

Hepatitis B - Basic 1

14:25-15:19

Hepatitis B - Basic 2

15:30-16:05

Hepatitis B - Basic 3

16:05-17:08

Hepatitis Delta 2
Room 06

08:00-08:49

Hepatitis B - Clinical 13

08:49-09:38

Hepatitis B - Clinical 14

09:38-10:27

Hepatitis B - Clinical 15

12:30-13:30

LS6 Miltenyi Biotec

13:40-14:34

Alcohol Related Liver Disease 1

14:34-15:09

Alcohol Related Liver Disease 2

15:30-16:05

Alcohol Related Liver Disease 3

16:05-16:32

Hepatitis C - Basic 1

16:32-17:17

Hepatitis Delta 1
Room 07

08:00-08:49

Hepatitis B - Clinical 16

08:49-09:45

Hepatitis B - Clinical 17

09:45-10:34

Hepatitis B - Clinical 18

13:40-14:34

Drug-Induced Liver Injury 1

14:34-15:23

Drug-Induced Liver Injury 2

15:30-16:12

Drug-Induced Liver Injury 3

16:19-16:54

Autoimmune and Cholestatic Disease 5
Room 08

08:00-08:49

Hepatitis B - Clinical 19

08:49-09:38

Hepatitis B - Clinical 20

09:38-10:34

Hepatitis B - Clinical 21

13:40-14:25

Autoimmune and Cholestatic Disease 1

14:25-15:01

Autoimmune and Cholestatic Disease 2

15:30-16:19

Autoimmune and Cholestatic Disease 3

16:19-17:08

Autoimmune and Cholestatic Disease 4
Room 09

08:00-09:00

MS1 Abbott

09:00-09:45

Metabolic-Associated Fatty Liver Disease - Clinical 1

13:40-15:10

HCV Elimination Policy Forum 2024

15:30-17:00

HCV Elimination Policy Forum 2024
Room 10

08:00-08:45

Metabolic-Associated Fatty Liver Disease - Clinical 2

08:45-09:30

Metabolic-Associated Fatty Liver Disease - Clinical 3

09:30-10:15

Metabolic-Associated Fatty Liver Disease - Clinical 4

13:40-15:10

Chugai Pharmaceutical

15:30-17:00

MAFLD 2 The Prognostic Event for MAFLD: CVD or Extrahepatic Cancers?
Room 11

08:00-08:45

Metabolic-Associated Fatty Liver Disease - Clinical 5

08:45-09:30

Metabolic-Associated Fatty Liver Disease - Clinical 6

09:30-10:24

Metabolic-Associated Fatty Liver Disease - Clinical 7

13:40-15:10

HCV 1 DAA Treatment for CHC in Asia Pacific Regio

15:30-17:00

HCV 2 Treatment with Direct Acting Antivirals (DAAs) for Cirrhotic Patients with or Without HCC
Room 12

08:00-08:54

Metabolic-Associated Fatty Liver Disease - Clinical 8

08:54-09:43

Metabolic-Associated Fatty Liver Disease - Clinical 9

09:43-10:32

Metabolic-Associated Fatty Liver Disease - Clinical 10

12:30-13:30

LS7 Novo Nordisk

13:40-15:10

MAFLD 3 Asian MAFLD: Basic Understanding (Molecular Pathogenesis)

15:30-17:00

HCV 3 Prognosis Portal Hypertension HCC in Post SVR CH-C/cirrhosis
Room 13

08:00-08:49

Metabolic-Associated Fatty Liver Disease - Clinical 11

08:49-09:38

Metabolic-Associated Fatty Liver Disease - Clinical 12

09:38-10:27

Metabolic-Associated Fatty Liver Disease - Clinical 13

12:30-13:30

LS8 Grifols

13:40-15:10

MAFLD 4 Clinical Management of MAFLD (Lifestyle Change Nutrition and Need of Medications)

15:30-17:00

MAFLD 5 Diagnosis of MAFLD
Room 14

08:00-08:49

Metabolic-Associated Fatty Liver Disease - Clinical 14

08:49-09:38

Metabolic-Associated Fatty Liver Disease - Clinical 15

09:38-10:34

Metabolic-Associated Fatty Liver Disease - Clinical 16

13:40-14:25

Hepatitis C - Clinical 1

14:25-15:19

Hepatitis C - Clinical 2

15:30-16:12

Hepatitis C - Clinical 5

16:12-16:54

Hepatitis C - Clinical 6
Room 15

08:00-08:45

Metabolic-Associated Fatty Liver Disease - Basic 1

08:45-09:34

Metabolic-Associated Fatty Liver Disease - Clinical 17

09:34-10:30

Metabolic-Associated Fatty Liver Disease - Clinical 18

13:40-14:29

Hepatitis C - Clinical 3

14:29-15:11

Hepatitis C - Clinical 4

15:30-16:06

Metabolic and Genetic Disease 1

16:06-16:42

Metabolic and Genetic Disease 2

16:42-17:17

Metabolic and Genetic Disease 3
Room 16

08:00-08:45

Metabolic-Associated Fatty Liver Disease - Basic 2

08:45-09:39

Metabolic-Associated Fatty Liver Disease - Basic 3

09:39-10:28

MetabolicAssociated Fatty Liver Disease-Basic 4

13:40-14:29

Metabolic-Associated Fatty Liver Disease - Basic 5

14:29-15:18

Metabolic-Associated Fatty Liver Disease - Basic 6

15:30-16:19

Metabolic-Associated Fatty Liver Disease - Basic 7

16:19-17:08

Metabolic-Associated Fatty Liver Disease - Basic 8
New Hall

17:10-18:10

Alcohol Related Liver Disease 1

17:10-18:10

Alcohol Related Liver Disease 2

17:10-18:10

Autoimmune and Cholestatic Disease

17:10-18:10

Autoimmune and Cholestatic Disease

17:10-18:10

Drug-Induced Liver Injury

17:10-18:10

Hepatitis B - Basic

17:10-18:10

Hepatitis B - Basic

17:10-18:10

Hepatitis B - Clinical

17:10-18:10

Hepatitis B - Clinical

17:10-18:10

Hepatitis B - Clinical

17:10-18:10

Hepatitis B - Clinical

17:10-18:10

Hepatitis B - Clinical

17:10-18:10

Hepatitis B - Clinical

17:10-18:10

Hepatitis B - Clinical

17:10-18:10

Hepatitis B - Clinical

17:10-18:10

Hepatitis B - Clinical

17:10-18:10

Hepatitis B - Clinical

17:10-18:10

Hepatitis C - Basic

17:10-18:10

Hepatitis C - Clinical

17:10-18:10

Hepatitis C - Clinical

17:10-18:10

Hepatitis C - Clinical

17:10-18:10

Hepatitis C - Clinical

17:10-18:10

Hepatitis C - Clinical

17:10-18:10

Hepatitis C - Clinical

17:10-18:10

Hepatitis C - Clinical

17:10-18:10

Hepatitis C - Clinical

17:10-18:10

Hepatitis Delta

17:10-18:10

Metabolic and Genetic Disease

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Basic

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Basic

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Basic

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Basic

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Basic

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Clinical

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Clinical

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Clinical

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Clinical

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Clinical

17:10-18:10

Hepatitis Delta

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Clinical

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Clinical

17:10-18:10

Metabolic-Associated Fatty Liver Disease - Clinical

17:10-18:10

Poster Session New Hall